A Prospective Pilot Randomized Study: Electroacupuncture vs. Sham Procedure for the Treatment of Fatigue in Patients With Quiescent Inflammatory Bowel Disease.

Inflammatory bowel disease (IBD) patients often experience persistent fatigue even when their disease is in remission. Researchers conducted a pilot study to test whether electroacupuncture could help reduce this debilitating symptom. Fifty-two IBD patients in remission who reported fatigue were randomly divided into three groups: one received real electroacupuncture, another received sham (fake) electroacupuncture, and the third was placed on a waitlist without treatment. Both acupuncture groups received nine treatment sessions over eight weeks. Fatigue levels were measured using a validated fatigue assessment scale. The results showed that both real and sham electroacupuncture significantly improved fatigue scores compared to baseline measurements. The real electroacupuncture group improved by an average of 9.53 points, while the sham group improved by 5.46 points. The waitlist group showed no significant changes. When comparing treatment groups directly, real electroacupuncture performed slightly better than sham, though this difference wasn't statistically significant. Importantly, both acupuncture groups showed significant improvements compared to the waitlist group. These findings suggest that acupuncture may provide meaningful relief for IBD patients struggling with fatigue, a symptom that has few effective treatment options. The researchers noted that the study wasn't large enough to definitively rule out differences between real and sham acupuncture, so larger trials are needed. For IBD patients dealing with persistent fatigue, acupuncture appears to be a safe option worth considering. If you're interested in trying acupuncture for IBD-related fatigue, seek treatment from a licensed acupuncturist with experience in treating chronic illness.

This single-blind randomized pilot study evaluated electroacupuncture (EAc) versus sham electroacupuncture (ShEAc) and waitlist (WL) controls for treating fatigue in quiescent IBD patients (n=52). Participants received nine treatment sessions over eight weeks. Fatigue was assessed using the IBD-validated FACIT-FS scale. Both EAc and ShEAc demonstrated significant improvements from baseline: EAc improved 9.53 points (95% CI: 6.75-12.3, P<0.001) and ShEAc improved 5.46 points (95% CI: 2.7-9.7, P=0.015), while WL showed no significant change. Direct comparison between treatment groups showed EAc nonsignificantly superior to ShEAc (33.27 vs 28.13, P=0.168), though both significantly outperformed WL (P=0.01 and P=0.04, respectively). Clinical takeaway: Electroacupuncture demonstrates potential efficacy for IBD-associated fatigue with clinically meaningful improvements, though the substantial sham response and small sample size warrant larger trials to establish specific treatment effects versus nonspecific therapeutic benefits.